Anti-Infective · General Oral/Topical
VOAZIIX-LB
Azithromycin 500 mg + Lactic Acid Bacillus 60 Million Spores
Manufactured at WHO-GMP certified facility by BIOFRIL HEALTHCARE. Available for hospital tender supply, ICU pharmacy, and PCD franchise distribution across India.
Product Specifications
VOAZIIX-LB at a Glance
| Brand Name | VOAZIIX-LB |
|---|---|
| Composition | Azithromycin 500 mg + Lactic Acid Bacillus 60 Million Spores |
| Therapeutic Category | Anti-Infective |
| Division | General Oral/Topical |
| Pack / Presentation | Tab. 10×3 Blister |
| Storage | Store below 25°C. Protect from light. |
| Manufacturer | BIOFRIL HEALTHCARE Pvt. Ltd. · WHO-GMP Plant, Nalagarh HP |
| Prescription Status | Schedule H — Sold on prescription of a Registered Medical Practitioner only |
Clinical Use
Indications & Clinical Applications
VOAZIIX-LB (Azithromycin 500 mg + Lactic Acid Bacillus 60 Million Spores) is indicated for the treatment of conditions in which Azithromycin 500 mg therapy is clinically appropriate. For complete prescribing information please refer to the official product insert.
Submit Enquiry for VOAZIIX-LB
PCD franchise · Hospital tender supply · Bulk procurement